Related by context. All words. (Click for frequent words.) 74 hepatic metastases 73 recurrent glioblastoma multiforme 73 superficial bladder cancer 72 renal tumors 72 metastatic RCC 72 cinacalcet 72 intravesical therapy 71 intravenous bisphosphonates 71 carcinoid tumors 71 preoperative chemotherapy 71 β blockers 71 differentiated thyroid 71 unresectable tumors 71 transarterial 71 leiomyomas 71 resectable 70 thoracoscopic lobectomy 70 chemoembolization 70 malignant pleural mesothelioma 70 epithelial tumors 70 antiangiogenic therapy 70 chemoradiation therapy 70 recurrent GBM 70 liver metastasis 70 hepatorenal syndrome 70 nicardipine 70 metastatic malignant 70 relapsed MM 70 pancreatic adenocarcinoma 70 paroxysmal AF 70 zotarolimus 70 concurrent chemoradiation 70 hyperoxaluria 70 NMIBC 70 Doxil ® 69 GnRH agonists 69 sorafenib Nexavar 69 invasive aspergillosis 69 mitomycin C 69 prostate carcinoma 69 ZOLINZA 69 paricalcitol 69 haematologic 69 aldosterone antagonists 69 recurrent glioblastoma 69 adjuvant radiotherapy 69 liver resection 69 intravesical 69 mucinous 69 colorectal adenoma 69 TACE 69 cytoreduction 69 radiotherapy RT 69 surgical revascularization 69 paclitaxel eluting stents 69 endometrial hyperplasia 69 gastric adenocarcinoma 69 fallopian tube cancers 69 symptomatic paroxysmal AF 69 neoadjuvant therapy 69 perioperatively 69 chemoradiotherapy 69 liposomal amphotericin B 69 hepatocellular carcinomas 69 ß blockers 69 external beam radiotherapy 68 rt PA 68 corticosteroid therapy 68 interferon alfa 2b 68 bladder carcinoma 68 peritoneal carcinomatosis 68 thalidomide Thalomid 68 CYT# potent vascular disrupting 68 radical nephrectomy 68 advanced adenomas 68 GISTs 68 thymectomy 68 rFVIIa 68 anterior uveitis 68 renal cell carcinomas 68 metastatic neuroendocrine tumors 68 neoadjuvant treatment 68 abacavir Ziagen 68 papillary renal cell carcinoma 68 glycoprotein IIb IIIa inhibitors 68 carotid artery stenting 68 neoadjuvant chemotherapy 68 adjuvant radiation 68 smoldering multiple myeloma 68 MGd 68 cranial irradiation 68 colorectal neoplasms 68 esophagogastric 68 curative resection 68 medically inoperable 68 AA Amyloidosis 68 basal cell carcinoma BCC 68 chlorambucil 68 null responder 68 Pemetrexed 68 5 Fluorouracil 68 Intravenous immunoglobulin 68 cytoreductive nephrectomy 68 ovarian carcinoma 68 allogeneic HSCT 68 lactulose 68 invasive candidiasis 68 ADPKD 68 metastatic malignant melanoma 68 metastatic GIST 68 sarcomatoid 68 abacavir lamivudine 68 antiarrhythmic drug 68 K ras mutations 68 intracranial hemorrhage ICH 68 antimicrobial prophylaxis 68 hypervascular tumors 68 alteplase 68 busulfan 68 sipuleucel T 68 metastatic gastric 68 Surgical resection 68 adenomatous 67 cisplatin chemotherapy 67 metastatic renal cell carcinoma 67 cytoreductive surgery 67 alkylating agent 67 erlotinib Tarceva ® 67 CIMZIA ™ 67 drug eluting stent implantation 67 INVEGA ® 67 PSADT 67 biliary tract cancer 67 gastrointestinal stromal tumors GIST 67 radiofrequency ablation RFA 67 flutamide 67 idarubicin 67 urothelial cancer 67 pulmonary metastases 67 allogeneic stem cell 67 anthracycline chemotherapy 67 GP IIb IIIa inhibitors 67 carotid endarterectomy CEA 67 FOLFOX6 67 liposomal doxorubicin 67 GIST tumors 67 relapsed SCLC 67 nephrotoxicity 67 Gliadel Wafer 67 primary hyperparathyroidism 67 thrombotic complications 67 serum phosphate 67 candidemia 67 SCIg 67 liver metastases 67 follicular lymphoma FL 67 BCG refractory 67 certolizumab 67 mycophenolate mofetil 67 fulvestrant 67 somatostatin analogues 67 colorectal cancer liver metastases 67 pamidronate 67 hypercalcemia 67 vWD 67 Flu Cy 67 FOLFOX4 67 bronchogenic carcinoma 67 antibiotic prophylaxis 67 VAPRISOL 67 Myelodysplastic Syndrome MDS 67 adalimumab Humira 67 ARB telmisartan 67 neoadjuvant 67 grade gliomas 67 relapsed ovarian cancer 67 Pegylated Liposomal Doxorubicin 67 postoperative morbidity 67 urothelial carcinoma 67 locoregional recurrence 67 primary aldosteronism 67 sirolimus eluting stents 67 NovoTTF 67 KRAS mutations occur 67 antithrombotic therapy 67 Capecitabine 67 infusional 67 trastuzumab Herceptin ® 67 TMP SMX 67 radiochemotherapy 67 contrast induced nephropathy 67 fallopian tube carcinoma 67 thromboembolic complications 67 achieved CCyR 67 BENICAR HCT 67 Adjuvant chemotherapy 67 rtPA 67 Mitomycin C 67 daunorubicin 67 leukemia AML 67 immunosuppressive therapies 67 ximelagatran 67 Retreatment 67 antibiotic regimens 67 gefitinib Iressa 67 fibrinolytic therapy 67 Hepatocellular Carcinoma HCC 67 hepatectomy 67 AGHD 67 intracoronary 67 Intra arterial 66 colorectal adenocarcinoma 66 UA NSTEMI 66 chemoresistant 66 ribavirin RBV 66 HoFH 66 bovine thrombin 66 anti angiogenic agents 66 deferiprone 66 prophylactic cranial irradiation 66 chronic GVHD 66 EBRT 66 malignant ascites 66 demonstrated antitumor activity 66 oncologic outcomes 66 completely resected 66 transurethral resection 66 secondary hyperparathyroidism 66 parathyroidectomy 66 Papillary 66 Hypotension 66 IV bisphosphonates 66 allogeneic hematopoietic stem cell 66 percutaneous drainage 66 postoperative chemotherapy 66 mRCC 66 artery embolization 66 mTOR inhibitors 66 interferon ribavirin 66 heavily pretreated 66 carotid stenosis 66 pericardial effusion 66 tumor histology 66 gastric carcinoma 66 stage IIIB 66 radioiodine therapy 66 KRAS mutant tumors 66 selective modulator 66 oral anticoagulation 66 hamartomas 66 ALA PDT 66 MYLOTARG 66 prostate adenocarcinoma 66 total thyroidectomy 66 hematopoietic cancers 66 pyridostigmine 66 cediranib 66 trans retinoic acid 66 Hurthle cell 66 macrolide antibiotic 66 HSCT 66 histologically confirmed 66 deep venous thromboses 66 pulmonary artery banding 66 receiving VELCADE 66 caspofungin 66 acute GvHD 66 prostate cancer PCa 66 oral antidiabetic medication 66 hepatoma 66 peginterferon 66 locoregional 66 intraperitoneal chemotherapy 66 chemotherapeutic regimens 66 prospectively stratified 66 KRAS mutation 66 Gleevec resistant 66 HGPIN 66 eosinophilic asthma 66 overt nephropathy 66 ACTEMRA TM 66 nephron sparing surgery 66 revascularization procedures 66 macroalbuminuria 66 IFN beta 66 CMV disease 66 SHPT 66 mutated K ras 66 chemoradiation 66 dasatinib Sprycel 66 antiplatelet drugs 66 Adjunctive 66 CANCIDAS 66 percutaneous vertebroplasty 66 NATRECOR ® 66 antiplatelet medications 66 Venous thromboembolism 66 iodixanol 66 BEXXAR Therapeutic Regimen 66 carmustine 66 severe renal impairment 66 hyperphenylalaninemia HPA due 66 Decitabine 66 aspirin clopidogrel 66 elevated LDH 66 Radiofrequency Ablation RFA 66 anagrelide 66 myopathy rhabdomyolysis 66 potentially hepatotoxic 66 conventional angiography 66 bezafibrate 66 cytotoxic therapy 66 RAS mutations 66 hypoperfusion 66 non squamous NSCLC 66 APTIVUS r 66 intestinal metaplasia 66 neointimal hyperplasia 66 Toxicities 66 stratifying patients 66 vinorelbine 66 membranous nephropathy 66 follicular lymphomas 66 DAPT 66 situ CIS 66 extrapleural pneumonectomy 66 prognostic variables 66 T2DM 66 tumor lysis syndrome 66 refractory NSCLC 66 NAVISTAR R 66 antithrombotic agents 66 glomerular filtration 66 bone scintigraphy 66 virological response 66 octreotide LAR 66 diabetes mellitus DM 66 cardiac perfusion 66 pharmacologically active isomer 66 calcineurin inhibitor 66 CsA 66 skeletal metastases 66 Xanafide 66 osteoporotic compression fractures 66 carotid artery stenting CAS 66 HIV HCV coinfected 66 denileukin diftitox 66 doxorubicin HCl liposome injection 66 grade glioma 66 radiation therapy SBRT 66 HER2 positive cancers 66 androgen ablation 66 TNF antagonist 66 ICD implantation 66 ketorolac 66 Natalizumab 66 postoperative AF 66 adrenalectomy 66 CTEPH 66 proliferative diabetic retinopathy 66 osteosarcomas 66 adenoidectomy 66 idraparinux 66 ablative therapy 66 squamous cell lung cancer 66 KRAS status 66 operable breast cancer 66 TNF alpha antagonist 66 catheter angiography 66 multivessel disease 66 EXJADE 66 octreotide 66 histopathologic examination 66 metastatic lung cancer 66 imatinib Gleevec 66 advanced adenoma 66 Naive Patients 65 plasminogen activators 65 renal cysts 65 FOSRENOL ® 65 oral clodronate 65 Vidaza azacitidine 65 Peginterferon 65 standard chemotherapy regimen 65 refractory CLL 65 GORE VIABAHN Endoprosthesis 65 pegylated liposomal doxorubicin 65 Degarelix 65 pulmonary hypertension PH 65 elective PCI 65 dosage regimens 65 TTF Therapy 65 nephrotoxic 65 femoral neck fractures 65 amphotericin B 65 lung metastases 65 ureteroscopy 65 hepatic arterial 65 INTEGRILIN R 65 lymphoid malignancies 65 teriflunomide 65 standard chemotherapy regimens 65 NSTE ACS 65 grade cervical intraepithelial 65 AZT zidovudine Retrovir 65 docetaxel Taxotere ® 65 morphometric vertebral fractures 65 mCRC patients 65 HER2 positive metastatic breast 65 prospective multicenter study 65 pancreatic NET 65 thrombocytopenic 65 NATRECOR R 65 Hematologic 65 tyrosine kinase inhibitors TKIs 65 recurrent metastatic 65 prostate cancer CRPC 65 Hodgkin lymphoma HL 65 IOP lowering 65 IFN alfa 65 taxane chemotherapy 65 titrated glipizide 65 nonalcoholic steatohepatitis NASH 65 oral anticoagulants 65 intra arterial 65 extracranial 65 vertebral compression fractures 65 interferon IFN 65 metastatic lymph nodes 65 clevidipine 65 postoperative atrial fibrillation 65 gastrointestinal stromal tumors 65 undetectable HBV DNA 65 rituximab Rituxan 65 VFEND 65 #F FDG PET 65 FDG PET imaging 65 monoclonal antibody conjugated 65 platelet inhibitor 65 recurrent NSCLC 65 occlusive disease 65 tricuspid regurgitation 65 nutlin 3a 65 efalizumab 65 docetaxel chemotherapy 65 anthracyclines taxanes 65 sunitinib Sutent 65 primary immunodeficiency PI 65 carotid angioplasty 65 Myelofibrosis 65 arteriography 65 PNH patients 65 mesalazine 65 malignant polyps 65 INCB# [003] 65 paclitaxel Taxol R 65 severe hypersensitivity reactions 65 resected pancreatic cancer 65 paracentesis 65 trabectedin 65 inhibitor RG# 65 Endometrial 65 prostate cancer CaP 65 lanreotide 65 endocrine therapies 65 CYPHER R Sirolimus eluting 65 thyroglobulin 65 riociguat 65 Accelerated Partial Breast Irradiation 65 gastrointestinal stromal tumor 65 saline placebo 65 infliximab Remicade 65 Fondaparinux 65 platelet reactivity 65 everolimus eluting stents 65 biliary strictures 65 Cyclosporine 65 pegylated liposomal doxorubicin PLD 65 immunomodulatory therapy 65 Doxorubicin 65 reduce serum phosphate 65 sclerosing 65 thyroid carcinoma 65 atherosclerotic lesions 65 Combination therapy 65 subconjunctival injection 65 renal denervation 65 cytotoxic chemotherapy 65 unresectable 65 intracavitary 65 Bezielle 65 histologic subtype 65 bleomycin 65 Radiofrequency ablation 65 Platinol ® cisplatin 65 Velcade bortezomib 65 vWF 65 Nilotinib 65 p# biomarker 65 Benign Prostatic Hyperplasia BPH 65 lipid lowering therapies 65 CTAP# Capsules 65 antihypertensive therapy 65 subcutaneous immunoglobulin 65 pegylated alpha interferon 65 severe exacerbations 65 FUSILEV enhances 65 stereotactic radiotherapy 65 Cloretazine 65 Glioblastoma Multiforme GBM 65 OPCAB 65 immunomodulatory agents 65 pharmacokinetic interactions 65 ER CHOP 65 ara C 65 carcinoid tumor 65 droperidol 65 polycythemia vera PV 65 complement inhibitor eculizumab 65 dopamine partial agonist 65 refractory AML 65 adriamycin 65 basal cell cancers 65 pleural effusions 65 dose cytarabine 65 thromboembolic disease 65 HER2 expression 65 receiving prophylactic anticoagulation 65 de novo AML 65 voriconazole 65 dalteparin 65 superficial femoral 65 HBeAg negative 65 Insulin detemir 65 diagnostic angiography 65 haematological cancers 65 moderate renal impairment 65 interferon therapy 65 urothelial bladder cancer 65 colorectal carcinoma 65 lenalidomide dexamethasone 65 paraganglioma 65 Tacrolimus 65 Vascugel 65 beta blocker therapy 65 endoscopic ultrasonography 65 Bortezomib 65 anticoagulant warfarin 65 ritonavir boosted 65 benign neoplasms 65 needle aspiration 65 HER2 overexpression 65 Gastrointestinal Stromal Tumors 65 osteoporotic vertebral compression fractures 65 metastatic lesions 65 symptomatic benign prostatic 65 colon resection 65 EUS FNA 65 bolus dose 65 viral kinetics 65 vinca alkaloids 65 prescribed proton pump 65 intradermal injections 65 receptor tyrosine kinase inhibitor 65 tenecteplase 65 salmeterol fluticasone 65 Lenalidomide 65 antiandrogens 65 antithrombotics 65 nonmetastatic 65 euthyroid 65 MAGE A3 ASCI 65 Zevalin consolidation 65 aripiprazole Abilify 65 invasive lobular carcinoma 65 Aliskiren 65 Bisphosphonate 65 tolterodine ER 65 cystectomy 65 underwent surgical resection 65 radical cystectomy 65 Fully Covered Stent 65 subependymal giant cell 65 STRIDE PD 65 noninvasive outpatient 65 alemtuzumab treated 65 severe neutropenia 65 invasive fungal infection 65 relapsing remitting MS RRMS 65 drug zotarolimus 65 F FDG PET 65 Renal Cell Carcinoma RCC 65 Teriflunomide 65 Pegylated Interferon 65 allogeneic HCT 65 TAXOTERE R 65 taxane therapy 65 decitabine 65 Surgical excision 65 Traficet EN 65 cetuximab Erbitux R 65 transcatheter aortic valve implantation 65 oral rivaroxaban 65 MGUS 65 B Cell Lymphoma 65 gadolinium enhanced 65 systemic corticosteroid 64 Abciximab 64 NAbs 64 MYCAMINE 64 CTAP# 64 LHRH agonists 64 thrombolytic agents 64 antithymocyte globulin 64 nodal metastases 64 osteoid osteoma 64 radiolabeled TM# 64 PCa 64 paragangliomas 64 calcineurin inhibitors 64 stable angina 64 deferoxamine 64 Tumor Response 64 TORISEL 64 urinary N telopeptide 64 pouchitis 64 AV fistulas 64 Pharmacokinetics PK 64 intestinal polyps 64 HeFH 64 methotrexate monotherapy 64 estramustine 64 oral anticoagulant therapy 64 thymic carcinoma 64 Orally administered 64 thromboembolic events 64 strontium ranelate 64 microsphere therapy 64 surgical debulking 64 thyroid nodules 64 somatostatin analogs 64 Tamibarotene 64 DOXIL 64 eculizumab therapy 64 inotropic agents 64 immunocompetent 64 #F FDG 64 adenoma 64 metaplasia 64 antiarrhythmic drugs 64 gastric corpus 64 atherosclerotic renal artery stenosis 64 Liver transplantation 64 QuadraSphere 64 iloprost 64 stage IIIb IV 64 PAOD 64 pentoxifylline 64 BoNTA 64 breast carcinoma 64 phosphate binders 64 tigecycline 64 BrachySil TM 64 myeloablative 64 myocardial revascularization 64 Solid Tumors 64 carcinoids 64 LNG IUS 64 Refractory Hodgkin Lymphoma 64 underwent resection 64 FASLODEX 64 lesional 64 diagnostic modality 64 autologous SCT 64 mitochondrial toxicity 64 panobinostat 64 nonmetastatic prostate cancer 64 direct thrombin inhibitors 64 ribavirin therapy 64 diabetic gastroparesis 64 zoledronate 64 superficial basal cell carcinoma 64 pT2 64 overactive bladder syndrome 64 adenocarcinomas 64 serum calcium levels 64 GLIADEL R Wafer 64 depsipeptide 64 ductal carcinomas 64 hA# 64 graft occlusion 64 hypertrophic scars 64 Stent thrombosis 64 patients undergoing CABG 64 relapsed refractory multiple myeloma 64 non squamous histology 64 pan HDAC inhibitor 64 ibandronate 64 atypical hyperplasia 64 Irinotecan 64 lipid lowering therapy 64 carcinoid 64 ertapenem 64 ALT elevations 64 polidocanol 64 Mitoxantrone 64 transthoracic 64 transcranial Doppler 64 carotid plaque 64 gadobutrol 64 dacarbazine chemotherapy 64 acetonide FA 64 epoetin alpha 64 cisplatin resistant 64 hemodialysis patients 64 HCV SPRINT 64 trans retinoic acid ATRA 64 IV NSCLC 64 lenalidomide Revlimid R 64 visilizumab 64 antiretroviral naïve 64 TLK# 64 histological subtype 64 medullary thyroid cancer 64 definite stent thrombosis 64 tacrolimus ointment 64 Ischemic 64 clomipramine 64 intravenously administered 64 CYPHER Stent 64 lymph node dissection 64 thrombocytopenic patients 64 angioplasty stenting 64 xanthine oxidase inhibitor 64 Melphalan 64 EBUS FNA 64 intravesical instillation 64 corticosteroid dose 64 transabdominal 64 resected 64 Chronic Myelogenous Leukemia 64 heparin induced thrombocytopenia 64 paclitaxel cisplatin 64 pain palliation 64 oxaliplatin Eloxatin 64 Follicular Lymphoma 64 bypass grafting 64 uricase 64 H. pylori eradication 64 LOVENOX R 64 primary hypercholesterolemia 64 adenoma recurrence 64 cidofovir 64 fibroadenomas 64 transarterial chemoembolization 64 mycophenolate mofetil MMF 64 Perforomist Inhalation Solution 64 Heavy menstrual bleeding 64 tumor resection 64 Platinol ® 64 HIPEC 64 Leucovorin 64 Acute Ischemic Stroke 64 GW# [003] 64 Teriparatide 64 papillary thyroid carcinoma 64 axillary dissection 64 Myelodysplastic Syndrome 64 cardiac troponin T 64 Methylnaltrexone 64 surgically resectable 64 myelofibrosis polycythemia vera 64 castration resistant prostate cancer 64 functional mitral regurgitation 64 elevated ALT 64 Percutaneous Coronary Intervention 64 curative therapy 64 urolithiasis 64 cerebral angiography 64 pneumonectomy 64 heavily pretreated patients 64 gp# vaccine 64 Neulasta ® 64 MMP inhibitors 64 evaluating tivozanib 64 methotrexate therapy 64 Carotid endarterectomy 64 5FU 64 intrahepatic 64 debulking surgery 64 recurrent DVT 64 intradermal injection 64 Tyrosine Kinase Inhibitor 64 receiving VICTRELIS 64 Estrogen Receptor 64 transaminase levels 64 PSA nadir 64 gastroduodenal 64 androgen deprivation 64 variceal hemorrhage 64 Malignant Glioma 64 Vaprisol 64 prostate TURP 64 biochemical recurrence 64 squamous histology 64 Radical prostatectomy 64 postoperative delirium 64 Postoperative complications 64 EoE 64 oblimersen 64 recombinant tissue plasminogen 64 indolent NHL 64 localized renal 64 treated nonsurgically 64 gemcitabine Gemzar 64 brain metastases 64 PROCHYMAL 64 risk reducing salpingo 64 Glioblastoma Multiforme 64 antitumor effect 64 pCR 64 cilengitide 64 pathologic diagnosis 64 immunosuppressive regimen 64 node metastases 64 hematologic toxicity 64 taxane resistant 64 sargramostim 64 FOLPI 64 dexrazoxane 64 malignant growths 64 pegylated interferon alfa 64 fibrinolysis 64 endometrial carcinoma 64 Cell Lymphoma CTCL 64 intraductal 64 resectable pancreatic cancer 64 dyslipidemias 64 nebulization 64 #I TM# 64 percutaneous cryoablation 64 AGILECT R 64 systemically administered 64 fosbretabulin 64 Enzyme Replacement Therapy 64 erythropoietic 64 Coronary Artery Bypass Graft 64 nonresponders 64 cardiotoxic 64 randomized multicenter trial 64 metastatic bladder 64 inflammatory acne 64 Cardiotoxicity 64 6 mercaptopurine 64 palliation 64 Dasatinib 64 fibrinolytic 64 transplantation HCT 64 Bacillus Calmette Guerin BCG 64 TPMT 64 gastrointestinal stromal tumor GIST 64 antiepileptics 64 non splenectomized 64 CINTREDEKIN BESUDOTOX 64 nab paclitaxel 64 resected tumors 64 antiemetics 64 rhIGF 64 relapsed ALL 64 Patients Receiving 64 follicular thyroid cancer 64 ritonavir boosted protease inhibitor 64 galiximab 64 Percutaneous vertebroplasty 64 nondiabetic patients 64 calculi 64 lanthanum carbonate 64 histologic findings 64 Rev Dex 64 cTnI 64 gemcitabine carboplatin 64 interstitial brachytherapy 64 femoral fractures 64 refractory ovarian cancer 64 cutaneous melanoma 64 Neovascular AMD 64 hyperplasia BPH 64 poor metabolizers 64 fludarabine cyclophosphamide 64 TEMODAL 64 liposomal formulation 64 tolvaptan 64 conventional coronary angiography 64 Elitek 64 surgical resection cavity 64 idiopathic myelofibrosis 64 antiandrogen 64 ALI ARDS 64 chemotherapeutic regimen 64 plasma pharmacokinetics 64 uridine triacetate 64 therapeutic regimens 64 cerebral vasospasm 64 adjuvant therapies 64 Atypical antipsychotics 64 HBsAg 63 androgen suppression 63 hyperacute 63 mutated KRAS gene 63 primidone 63 CR# vcMMAE 63 MAL PDT 63 PegIntron 63 Chronic Lymphocytic Leukemia CLL 63 nephrectomy 63 Beta catenin pathway 63 interferon alfa 2a 63 lymphadenectomy 63 periprocedural 63 unstable angina UA 63 pseudoaneurysm 63 adverse cytogenetics 63 labetalol 63 Ceplene/IL-2 63 Virologic 63 milrinone 63 EVIZON 63 urography 63 artery stenosis 63 FDG-PET/CT 63 neoadjuvant radiation 63 noninferior 63 Acute Myeloid Leukaemia AML 63 verteporfin 63 ASCUS 63 eribulin mesylate 63 fluvastatin 63 lichen planus 63 duplex ultrasonography 63 nimodipine 63 total abdominal hysterectomy 63 allogeneic transplants 63 esophageal gastric 63 Peginterferon alfa 2b 63 imatinib therapy 63 recurrent malignant glioma 63 steroid dexamethasone 63 ABVD 63 noncardiac 63 cranial radiation 63 systemic fungal infections 63 psoriatic arthritis PsA 63 bendamustine 63 non resectable 63 Endarterectomy 63 sunitinib malate 63 rebleeding 63 biochemical relapse 63 dose melphalan 63 pimecrolimus 63 cirrhotic patients 63 remission induction 63 alanine aminotransferase ALT 63 complete cytogenetic response 63 weekly intravenous infusions 63 imatinib resistance 63 interstitial pneumonia 63 postsurgical 63 iPTH 63 advanced hepatocellular carcinoma 63 malignant lymphoma 63 intracranial stenosis 63 sentinel lymph node biopsy 63 rhGH 63 pancreatectomy 63 TAXUS Express Stent 63 Acute myeloid leukemia 63 histone deacetylase inhibitor 63 indolent lymphomas 63 percutaneous nephrolithotomy 63 esophagitis 63 cystoscopic 63 invasive ductal 63 neointimal 63 non metastatic osteosarcoma 63 Erlotinib 63 anthracycline taxane 63 Nebulized 63 5alpha reductase 63 acetabular fractures 63 Castration Resistant Prostate Cancer 63 spiral computed tomography 63 LEUKINE 63 micafungin 63 tocilizumab 63 tumor necrosis 63 tipranavir ritonavir 63 FIRMAGON 63 either acutely decompensated